Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger SWIM-type containing 6 (ZSWIM6) encodes a highly conserved zinc finger protein with a SWIM (SWI2/SNF2 and MuDR) domain that is predicted to interact with DNA or proteins. It is critical for embryonic development, particularly the formation of craniofacial structures, the brain, and limbs. Variants in the gene are associated with disorders such as acromelic frontonasal dysostosis (characterized by frontonasal dysplasia, midline brain anomalies, and limb malformations) as well as neurodevelopmental syndromes. Functional studies show ZSWIM6 is expressed throughout the nervous system during early development, and its disruption is linked to altered Hedgehog pathway signaling and neuronal differentiation. Currently, there are no approved drugs targeting ZSWIM6, and it is not considered a classical therapeutic target, but rather a protein of developmental and genetic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger SWIM-type containing 6 (ZSWIM6).